Regeneus Ltd (
As announced on Friday, the company has entered into an R&D loan facility agreement and has drawn down $1 million. The funds will be utilised in operational expenditure.
About Regeneus Ltd
Regeneus Ltd (ASX:RGS) is a Sydney-based clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies. The regenerative therapies seek to address unmet medical needs in human health markets, focusing on neuropathic pain, including osteoarthritis and various skin conditions, with its platform technologies Progenza(TM) and Sygenus. Visit www.regeneus.com.au for more information.
Contact
Sandra McIntoshCompany Secretary
Regeneus Ltd
T: +61-2-9499-8010
E: investors@regeneus.com.au
W: www.regeneus.com.au
Related Companies
Related Industry Topics: